CLINICAL_TRIALS
trial_result
· 2022-10-10
Clinical Trial Update: Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients [Phase 2]
Summary
Phase 2 trial assessing efficacy and safety of oral DS107 in moderate to severe atopic dermatitis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: DS Biopharma | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2022-10-10